Biosimilars are transforming care by improving access and cutting costs. Discover insights from a survey on their adoption at National Cancer Institute–designated cancer centers. Where does your institution fit in? https://t.co/UqKB7kP0V0 #Biosimilars #CancerCare @theNCI

Happy Thanksgiving from all of us to you! We’re so grateful for the opportunity to work with amazing people, serve a wonderful community, and make a difference every day. Thank you for your support! 🍂🦃 #Gratitude #Thanksgiving

Patients with multiple myeloma have a high risk of VTE, making thromboprophylaxis essential. Learn valuable insights into the safety and effectiveness of direct oral anticoagulants in preventing VTE: https://t.co/tqXERQAMPu #MultipleMyeloma #VTEPrevention #Oncology #CancerCare

This case report highlights a rare instance of irinotecan-induced hypertonia, shedding light on this uncommon side effect of chemotherapy. Learn the importance of recognizing and managing such adverse events: https://t.co/i2rc0mxINm #Chemotherapy #CancerCare #AdverseEffects

Game-changer in gastric cancer treatment? See how researchers are evaluating the use of fam-trastuzumab deruxtecan in patients with advanced or metastatic gastric and gastroesophageal junction adenocarcinoma: https://t.co/PqXp1345Ow #CancerResearch #GastricCancer #CancerTreatment

For patients on PARP inhibitors, early adverse events often lead to therapy changes. Read how pharmacist-led monitoring is changing the game for some of these patients: https://t.co/J4rQ7wwOJX #Pharmacist #PARPInhibitors #OncologyResearch #ImprovingPatientOutcomes

Hear from Dr. Greg Kalemkerian, a leading medical oncologist and professor at the University of Michigan, as he provides expert insights into the evolving landscape of lung cancer treatment: https://t.co/mFMIJW8Bwn #LungCancer #CancerResearch #CancerTreatment #ASCO25

Did you know stomach cancer is the 5th most common cancer worldwide? This November, we recognize Stomach Cancer Awareness Month and the importance of education, early detection, and hope. 💙 #StomachCancerAwareness #StomachCancer #EarlyDetection

Today we're taking a break from the science and seriousness to wish you a spooktacular and safe Halloween! 👻🧪 Dressing up for the occasion? Show us your boo-tiful costumes! 🕸️✨ #Halloween #Halloween2025 #TrickOrTreat #AllTheTreats

SAVED and IMPEDE scores help predict blood clot risks in MM patients on IMiDs, but what role do specialty pharmacists play in prevention? This study looks at anticoagulation therapy adherence: https://t.co/66nQEl6JFp #VTECare #CancerResearch #MultipleMyeloma #HemOnc

🔬 GI cancer patients face risks with oral blood thinners. While guidelines favor low-molecular-weight heparin, new research explores the safety of apixaban and rivaroxaban for treating clots. Learn more: https://t.co/rjIu3yDI15 #OncologyCare #VTE #CancerResearch #PatientSafety

🎉💊 Happy National Pharmacy Technician Day! 💊🎉 Today we celebrate the unsung heroes of healthcare, pharmacy technicians! Tag a pharmacy tech today and let them know how much they’re appreciated! 💙 #PharmacyTechnicianDay #ThankATech #HealthcareHeroes #PharmacyLife

In this article, we highlight severe rhabdomyolysis in a patient with advanced breast cancer from an interaction of palbociclib (CYP3A4 inhibitor) and simvastatin (CYP3A4 substrate): https://t.co/nbgvh9hCei #DrugSafety #CancerCare #DrugInteractions #PatientSafety #BreastCancer

🎉💊 October is American Pharmacists Month! 💊🎉 Let’s celebrate the incredible pharmacists who go above and beyond to keep us healthy, safe, and informed. Tag your favorite pharmacist and show them some love today! 💙 #AmericanPharmacistsMonth #ThankAPharmacist #PharmacyCare

💙 World Hospice & Palliative Care Day 💙 Today highlights the importance of interdisciplinary collaboration, evidence-based symptom management, and compassionate care to ensure patients and families receive guidance, comfort, and dignity. #WHPCDay #HospiceCare #PalliativeCare

This month, support breast cancer awareness by promoting early diagnosis! This study explores patients with hormone receptor–positive/HER2-negative, node-positive early breast cancer starting abemaciclib: https://t.co/oB0ZtpmEkL #BreastCancer #EarlyDetection #FromTheArchives

This article describes a case of rhabdomyolysis in a patient with advanced breast cancer, as a result of an interaction between palbociclib. Click for details and advice on safer coadministration: https://t.co/nTY1ogJBcV #Pharmacists #BreastCancer #DrugInteraction

September is Prostate Cancer Awareness Month - a time to highlight the importance of early detection and proactive health. Men over 50 (or over 40 with risk factors). Have THAT conversation with someone - you might save a life! #ProstateCancer #EarlyDetection #CancerScreening

HSCT is a complication that increases the risk of morbidity and mortality. Could eltrombopag be the solution? This review of 67 patients sheds light on its potential as a treatment for post-HSCT thrombocytopenia: https://t.co/LGC5KC92vL #HSCT #Thrombocytopenia #Eltrombopag

It's World Lymphoma Day! A day dedicated to raising awareness about lymphoma and supporting those impacted by this form of blood cancer. Education, early diagnosis, and supporting ongoing research are key to improving outcomes. #WorldLymphomaDay #LymphomaAwareness #BloodCancer